U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced a new federal initiative to build a comprehensive autism data platform using Medicare and Medicaid records. Designed to study the causes of autism spectrum disorder (ASD), the platform will integrate claims data, electronic health records, and data from wearable health devices, according to the Department of Health and Human Services (HHS).
The National Institutes of Health (NIH) and the Centers for Medicare and Medicaid Services (CMS) will collaborate on the effort, which is part of a broader $50 million research initiative to investigate potential environmental and medical causes of autism. Kennedy stated the project aims to provide "honest answers families have waited far too long to hear," despite his controversial history promoting a debunked link between vaccines and autism.
HHS said the platform will help researchers analyze autism diagnoses, treatment outcomes, healthcare access disparities, and the financial impact on families. However, experts like Dr. Helen Tager-Flusberg of Boston University argue the focus does not directly address autism’s root causes. She also noted that an existing NIH autism database recently went offline without explanation, raising concerns about transparency.
The project has sparked privacy questions, as HHS has not confirmed whether the database will be anonymous or voluntary. Autism researcher Eric Rubenstein noted that Medicaid and Medicare data offer insights into health disparities but lack environmental exposure data, which Kennedy claims he will explore.
Autism rates have surged in recent years, with the CDC reporting 1 in 31 U.S. 8-year-olds diagnosed in 2022. While Kennedy aims to identify autism’s causes by September, scientists emphasize that autism likely stems from a complex mix of genetic and environmental factors. Critics warn against oversimplifying this ongoing scientific challenge.


Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
United States Officially Exits World Health Organization, Raising Global Public Health Concerns
ICE Blocked From Entering Ecuador Consulate in Minneapolis During Immigration Operation
Trump to Announce New Federal Reserve Chair Pick as Powell Replacement Looms
Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment
More Than 100 Venezuelan Political Prisoners Released Amid Ongoing Human Rights Scrutiny
Trump Family Files $10 Billion Lawsuit Over IRS Tax Disclosure
Japan Urges Fishermen to Avoid Senkaku Islands as China Tensions Rise
Trump Orders DHS to Avoid Protests in Democratic Cities Unless Federal Assets Are Threatened
FCC Chairman Raises Competition Concerns Over Netflix–Warner Bros. Discovery Deal
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
China to Add Eli Lilly’s Mounjaro to National Health Insurance in 2025
China Approves First Import Batch of Nvidia H200 AI Chips Amid Strategic Shift
Panama Supreme Court Voids CK Hutchison Port Concessions, Raising Geopolitical and Trade Concerns
SEC Drops Gemini Enforcement Case After Full Repayment to Earn Investors 



